Pancreatic stent placement for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: Do we need further evidence? No, the defense rests

Endoscopy

Volumn 42, Issue 10, 2010, Pages 870-871

  Rao, A S ^a   Baron, T H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON DILATATION; CANNULATION; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; ODDI SPHINCTER; PANCREAS DUCT; PANCREATIC DUCT STENTING; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; RISK REDUCTION; SPHINCTEROTOMY; STENT; VATER PAPILLA STENOSIS;

ACUTE DISEASE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; STENTS;

EID: 77957318913     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1255754     Document Type: Editorial

References (16)

1. Kamisawa T, Egawa N, Nakajima H et al. Clinical significance of the accessory pancreatic duct. Hepatogastroenterology 2003 50 2196-2198 (Pubitemid 37468026)
2. Smithline A, Silverman W, Rogers D et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993 39 652-657
3. Tarnasky P R., Palesch Y Y., Cunningham J T. et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998 115 1518-1524
4. Dumonceau J M., Andriulli A, Deviere J et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010 42 503-515
5. Dumonceau J M., Rigaux J, Kahaleh M et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc 2010 71 934-939
6. Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010 42 842-853
7. Kennedy P T., Russo E, Kumar N et al. The safety and utility of prophylactic pancreatic duct stents in the prevention of post-ERCP pancreatitis: an analysis of practice in a single UK tertiary referral center. Surg Endosc 2010 24 1923-1928
8. Freeman M L. Role of pancreatic stents in prevention of post-ERCP pancreatitis. JOP 2004 5 322-327
9. Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004 60 544-550
10. Andriulli A, Forlano R, Napolitano G et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007 75 156-163
11. Freeman M L., Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004 59 8-14
12. Price L H., Brandabur J J., Kozarek R A. et al. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc 2009 70 174-179
13. Chahal P, Tarnasky P R., Petersen B T. et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009 7 834-839
14. Rashdan A, Fogel E L., McHenry L Jr et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004 2 322-329
15. Lawrence C, Cotton P B., Romagnuolo J et al. Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities. Endoscopy 2007 39 1082-1085
16. Bakman Y G., Safdar K, Freeman M L. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009 41 1095-1098